Cisplatin efficacy

Author: nbde

August undefined, 2024

WebSep 27, 2016 · PURPOSE Paclitaxel, ifosfamide, and cisplatin (TIP) achieved complete responses (CRs) in two thirds of patients with advanced germ cell tumors (GCTs) who relapsed after first-line chemotherapy with cisplatin and etoposide with or without bleomycin. We tested the efficacy of first-line TIP in patients with intermediate- or poor … WebThe efficacy of cisplatin must be improved for the treatment of UTUC because most patients with UTUC are older and may have renal insufficiency. The inadequate dose of cisplatin consequently leading to a poor outcome is a clinical challenge.

Cisplatin Uses, Side Effects & Warnings - Drugs.com

WebApr 14, 2024 · This overall positive outlook is marred by the development of resistance or reduced efficacy of the drug combinations, but the underlying mechanisms are somewhat unclear. It is interesting to note that cancer cells quickly adapt and evade most therapies by activating autophagy, a catabolic process designed to recycle damaged cellular … WebApr 5, 2024 · This is a single-arm, single-center, exploratory study, the purpose of this study is to evaluate the efficacy and safety of envafolimab combined with Chemoradiotherapy in participants with locally advanced cervical cancer. Condition or disease ... such as envafolimab and cisplatin; Subjects who have concomitant diseases that, in the ... chip sigmon in charlotte nc

Cisplatin plus anti-PD-1 antibody enhanced treatment efficacy in ...

WebMar 28, 2024 · Approximately two-thirds of patients with PDAC are diagnosed at a metastatic stage. 5 In this setting, the treatment relies on systemic chemotherapy, but options are limited. Following more than 15 years of use of gemcitabine alone as standard, the FOLFIRINOX (5-fluorouracil administered as leucovorin and 5-fluorouracil (LV5FU2), … WebCisplatin is approved to be used alone or with other drugs to treat: Bladder cancer. It is used alone in patients with advanced cancer that cannot be treated with other therapies, … WebJul 12, 2024 · Here the authors report the results of a randomized phase 3 trial to compare the efficacy of first-line nab-paclitaxel/cisplatin to gemcitabine/cisplatin in patients with TNBC. chip sign in

CRISPR/Cas9-based genome-wide screening for …

Sodium Thiosulfate for Protection from Cisplatin-Induced …

WebJul 8, 2024 · Multicenter, randomized, open-label, parallel group phase 2 study to assess the efficacy and tolerance of four combinations of CBP501, cisplatin, and nivolumab administered once every 21 days to patients with stage IV exocrine pancreatic cancer and WBC < 10,000/mm3 at screening. WebSep 20, 2024 · Efficacy was evaluated in two multicenter open-label, randomized controlled trials in pediatric patients undergoing treatment with cisplatin-based chemotherapy for … chi psi fraternity uwWebJun 13, 2024 · Cisplatin was the first platinum compound to gain approval by the US Food and Drug Administration (FDA), in 1978. Its mechanism of action is through its ability to bind to DNA, via purine base crosslinking, … graphene accelerometer

"WebJul 3, 2024 · These include blockade of cisplatin entry into the cochlear fluid or hair cells. Further, antioxidants are among the most extensively studied agents due to the importance of ROS in ototoxicity. However, a concern exists that the chemotherapeutic efficacy of cisplatin may be reduced (Block et al., 2009). Reductions in inflammatory cytokine ... " - Cisplatin efficacy

Cisplatin efficacy

Cisplatin/gemcitabine/pirarubicin SpringerLink

WebCisplatin : an old drug with a newfound efficacy -- from mechanisms of action to cytotoxicity Although cisplatin has been used for a long time, only recently its exact mechanism of action has been better defined. WebApr 11, 2024 · Importantly, inhibition of STAT3 signaling significantly attenuated MB tumor growth in subcutaneous and intracranial orthotopic xenografts, increased the sensitivity of MB tumors to cisplatin, and improved the survival of …

Did you know?

WebOct 1, 2024 · Enhancement of cisplatin efficacy by lipid-CaO 2 nanocarrier-mediated comprehensive modulation of the tumor microenvironment. Hypoxia, acidosis and high … WebJan 13, 2024 · Indeed, after decades of research on antioxidants optimized for scheduling, dose, potency, and method of administration, no antioxidant therapy has demonstrated enough efficacy to be widely accepted as a therapy for cisplatin ototoxicity. Despite some limitations of antioxidants, several have moved toward a clinical trial.

WebApr 5, 2024 · Concurrent chemoradiotherapy with 3-weekly cisplatin 100 mg/m 2 has been the standard of care for locoregionally advanced head and neck cancer (LA-HNC) with level I evidence. While the outcomes in terms of efficacy have been well established, the toxicity profile, compliance, and real-world applicability has been an area of ongoing concern for … WebApr 15, 2024 · A 64-year-old man exhibited lack of efficacy during treatment with pirarubicin, gemcitabine and cisplatin for metastatic, high-grade non-muscle invasive …

WebDec 9, 2024 · But efficacy and toxicity of nedaplatin, lobaplatin and cisplatin haven’t been directly compared in concurrent chemo-radiotherapy in a study due to lack of head-to-head comparative trial. This retrospective study was done to compare short-term response rate, toxicity and long-term survival of cisplatin, nedaplatin and lobaplatin in concurrent ... WebCisplatin (DDP) is a common therapeutic option for non-small cell lung carcinoma (NSCLC). However, some patients fail to respond to the DDP chemotherapy. ... 11 with an overall five-year survival of just 16%. 12 Therefore, improving the efficacy of DDP chemotherapy and sequential treatment after the failure of the DDP chemotherapy is crucial to ...

WebMay 26, 2024 · Efficacy The full analysis set included 26 (83.9%) patients who received at least one dose of study drug, had a baseline scan, and had at least one post-baseline disease assessment. Four (15.4%)...

WebMar 15, 2024 · The incidence of ototoxicity induced by cisplatin has been estimated to be 36% of adult patients with cancer and 40%-60% of pediatric patients.2 … chip signal download chi psi fraternity seattleWebCisplatin is a widely used cytotoxic agent approved in the treatment of bladder, ovarian, testicular, cervical, head and neck, and nonsmall cell lung cancer [ 1 – 3 ]. Cisplatin was first documented in 1847 by M. Peyrone, and it was approved by FDA for a variety of cancers in 1978. graphenea companyWebApr 15, 2024 · A 64-year-old man exhibited lack of efficacy during treatment with pirarubicin, gemcitabine and cisplatin for metastatic, high-grade non-muscle invasive bladder urothelial carcinoma. Additionally, he also developed severe dizziness, nausea and vomiting during treatment with gemcitabine and cisplatin for metastatic high-grade non … chip sigmaWebThis enhanced drug efficacy could be attributable to Rev7’s ability to promote cisplatin resistance via the TLS DNA damage tolerance pathway and/or its regulation of DSB repair pathway choice. Indeed, Rev7 inactivation enhances cisplatin efficacy beyond that seen with disruption of other Pol ζ-components ( 5 ), suggesting that the effects of ... chip sign in united healthcareWebJun 1, 2024 · A phase 2 trial of durvalumab in combination with gemcitabine and cisplatin demonstrated promising efficacy, with an objective response rate of 72% and a median overall survival of 20.2 months and without dose-limiting toxicity, in a nonrandomized, single-center study, establishing proof of concept for this approach in advanced biliary tract ... graphene adoptionWebMar 17, 2024 · Cisplatin DNA-adduct positivity in primary tumors increased upon OMO-1 treatment in a dose-dependent manner, being significantly higher with cisplatin + 12.5 … graphenea empleo